Tag Archives: survival

ASCO: J&J pads case for new Erleada use with prostate cancer survival data

CHICAGO—Johnson & Johnson’s Erleada may be the follow-up to blockbuster Zytiga, but it’s also ready to go where its predecessor hasn’t gone before. Friday at the American Society of Clinical Oncology annual meeting, the New Jersey drugmaker rolled out results showing that adding Erleada to androgen deprivation therapy (ADT) cut the risk of death by 33%… Read More »

Even hospitals with high patient survival rates still struggle with readmissions

Cardiology patients have better survival rates at hospitals atop the U.S. News and World Report rankings, but the risk of readmission is more or less the same — and with 30-day readmissions tied to reimbursement, that could pose an issue for providers at all points on the spectrum. The top 50 hospitals showed consistently low… Read More »